ImmunityBio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IBRX research report →
About the company
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases.
- CEO
- Richard Gerald Adcock
- IPO
- 2015
- Employees
- 671
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $9.89B
- P/E
- -11.06
- P/S
- 70.13
- P/B
- -11.14
- EV/EBITDA
- -14.88
- Div Yield
- 0.00%
- Gross Margin
- 93.79%
- Op Margin
- -185.41%
- Net Margin
- -606.15%
- ROE
- 138.69%
- ROIC
- -44.51%
- Revenue
- $113.29M · 668.31%
- Net Income
- $-351,398,000 · 15.03%
- EPS
- $-0.38 · 35.59%
- Op Income
- $-256,027,000
- FCF YoY
- 22.44%
- 52W High
- $12.43
- 52W Low
- $1.95
- 50D MA
- $7.68
- 200D MA
- $5.40
- Beta
- 0.10
- Avg Volume
- 13.97M
Get TickerSpark's AI analysis on IBRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | Selecky Christobel | other | 30,000 |
| Jun 29, 26 | Selecky Christobel | other | 33,549 |
| Jun 30, 26 | Selecky Christobel | other | 300 |
| Jun 29, 26 | Selecky Christobel | other | 30,000 |
| Jun 29, 26 | Selecky Christobel | other | 33,549 |
| Jun 29, 26 | Selecky Christobel | other | 32,173 |
| Jun 30, 26 | Selecky Christobel | other | 700 |
| Jun 29, 26 | Selecky Christobel | other | 32,173 |
| Jun 30, 26 | Selecky Christobel | other | 300 |
| Jun 30, 26 | Selecky Christobel | other | 700 |
Our IBRX coverage
Recent articles, reports, and earnings notes.
No research on IBRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBRX report →Similar companies
Peers in the same neighborhood.